These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. Liu Y; Geng YH; Yang H; Yang H; Zhou YT; Zhang HQ; Tian XX; Fang WG Cancer Lett; 2018 Aug; 430():1-10. PubMed ID: 29733962 [TBL] [Abstract][Full Text] [Related]
23. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Sherbet GV Cancer Lett; 2009 Jul; 280(1):15-30. PubMed ID: 19059703 [TBL] [Abstract][Full Text] [Related]
24. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Zhao Y; Zhang T; Wang Q Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849 [TBL] [Abstract][Full Text] [Related]
25. Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Klingelhöfer J; Senolt L; Baslund B; Nielsen GH; Skibshøj I; Pavelka K; Neidhart M; Gay S; Ambartsumian N; Hansen BS; Petersen J; Lukanidin E; Grigorian M Arthritis Rheum; 2007 Mar; 56(3):779-89. PubMed ID: 17328050 [TBL] [Abstract][Full Text] [Related]
26. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers. Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047 [TBL] [Abstract][Full Text] [Related]
27. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion. Jin T; Zhang Z; Yang XF; Luo JS Asian Pac J Cancer Prev; 2015; 16(7):2883-7. PubMed ID: 25854377 [TBL] [Abstract][Full Text] [Related]
28. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Wang L; Wang X; Liang Y; Diao X; Chen Q Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804 [TBL] [Abstract][Full Text] [Related]
29. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Sekine H; Chen N; Sato K; Saiki Y; Yoshino Y; Umetsu Y; Jin G; Nagase H; Gu Z; Fukushige S; Sunamura M; Horii A Biochem Biophys Res Commun; 2012 Dec; 429(3-4):214-9. PubMed ID: 23085231 [TBL] [Abstract][Full Text] [Related]
30. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4. Hua T; Wang X; Chi S; Liu Y; Feng D; Zhao Y; Wang H Oncol Rep; 2018 Aug; 40(2):823-832. PubMed ID: 29901152 [TBL] [Abstract][Full Text] [Related]
31. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion. Kim TH; Kim HI; Soung YH; Shaw LA; Chung J Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905 [TBL] [Abstract][Full Text] [Related]
32. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538 [TBL] [Abstract][Full Text] [Related]
33. The level of the Phf10 protein, a PBAF chromatin-remodeling complex subunit, correlates with the Mts1/S100A4 expression in human cancer cell lines. Soshnikova NV; Simonov YP; Brechalov AV; Portseva TN; Pankratova EV; Georgieva SG Dokl Biochem Biophys; 2016 Mar; 467(1):162-4. PubMed ID: 27193724 [TBL] [Abstract][Full Text] [Related]
34. Molecular inhibition mechanisms of cell migration and invasion by coix polysaccharides in A549 NSCLC cells via targeting S100A4. Luo C; Wang X; An C; Hwang CF; Miao W; Yang L; Xu M; Bai A; Deng S Mol Med Rep; 2017 Jan; 15(1):309-316. PubMed ID: 27922683 [TBL] [Abstract][Full Text] [Related]
35. The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies. Cerezo LA; Kuncová K; Mann H; Tomcík M; Zámecník J; Lukanidin E; Neidhart M; Gay S; Grigorian M; Vencovsky J; Senolt L Rheumatology (Oxford); 2011 Oct; 50(10):1766-72. PubMed ID: 21712367 [TBL] [Abstract][Full Text] [Related]
36. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide. Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879 [TBL] [Abstract][Full Text] [Related]
37. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4. He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128 [TBL] [Abstract][Full Text] [Related]
38. Expression and Functional Analysis of Tumor-Related Factor S100A4 in Antler Stem Cells. Wang DT; Chu WH; Sun HM; Ba HX; Li CY J Histochem Cytochem; 2017 Oct; 65(10):579-591. PubMed ID: 28832242 [TBL] [Abstract][Full Text] [Related]
39. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Mishra SK; Siddique HR; Saleem M Cancer Metastasis Rev; 2012 Jun; 31(1-2):163-72. PubMed ID: 22109080 [TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression. Mudduluru G; Ilm K; Fuchs S; Stein U Oncotarget; 2017 Mar; 8(13):21081-21094. PubMed ID: 28423501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]